Shen Aling, Lin Wei, Chen Youqin, Liu Liya, Chen Hongwei, Zhuang Qunchuan, Lin Jiumao, Sferra Thomas J, Peng Jun
Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Minhou Shangjie, Fuzhou, Fujian 350122, P.R. China.
Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Int J Oncol. 2015 Feb;46(2):685-90. doi: 10.3892/ijo.2014.2772. Epub 2014 Nov 24.
Tumor metastasis, a complex process involving the spread of malignant tumor cells from a primary tumor site to a distant organ, is a major cause of failure of cancer chemotherapy. Epithelial-mesenchymal transition (EMT) is a critical step for the initiation of cancer metastasis. The processes of EMT and metastasis are highly regulated by a double-negative feedback loop consisting of TGF-β1/ZEB pathway and miR-200 family, which therefore has become a promising target for cancer chemotherapy. Pien Tze Huang (PZH), a well-known traditional Chinese formula first prescribed in the Ming Dynasty, has been demonstrated to be clinically effective in the treatment of various types of human malignancy including colorectal cancer (CRC). Our published data proposed that PZH was able to induce apoptosis, inhibit cell proliferation and tumor angiogenesis, leading to the suppression of CRC growth in vitro and in vivo. To further elucidate the mode of action of PZH, in the present study we evaluated its effects on the metastatic capacities of human colorectal carcinoma HCT-8 cells and investigated the underlying molecular mechanisms. We found that PZH significantly inhibited the migration and invasion of HCT-8 cells in a dose-dependent manner. In addition, PZH treatment inhibited the expression of key mediators of TGF-β1 signaling, such as TGF-β1, Smad2/3 and Smad4. Moreover, PZH treatment suppressed the expression of ZEB1 and ZEB2, two critical target genes of TGF-β1 pathway, leading to a decrease in the expression of mesenchymal marker N-cadherin and an increased expression of epithelial marker E-cadherin. Furthermore, PZH treatment upregulated the expression of miR-200a, miR-200b and miR-200c. Collectively, our findings in this study suggest that PZH can inhibit metastasis of colorectal cancer cells via modulating TGF-β1/ZEB/miR-200 signaling network, which might be one of the mechanisms whereby PZH exerts its anticancer function.
肿瘤转移是一个复杂的过程,涉及恶性肿瘤细胞从原发肿瘤部位扩散到远处器官,是癌症化疗失败的主要原因。上皮-间质转化(EMT)是癌症转移起始的关键步骤。EMT和转移过程受到由TGF-β1/ZEB通路和miR-200家族组成的双负反馈回路的高度调控,因此该回路已成为癌症化疗的一个有前景的靶点。片仔癀(PZH)是一种著名的传统中药配方,最早在明朝就已被记载,已被证明在治疗包括结直肠癌(CRC)在内的各种人类恶性肿瘤方面具有临床疗效。我们已发表的数据表明,PZH能够诱导细胞凋亡、抑制细胞增殖和肿瘤血管生成,从而在体外和体内抑制CRC的生长。为了进一步阐明PZH的作用模式,在本研究中,我们评估了其对人结肠癌细胞HCT-8转移能力的影响,并研究了潜在的分子机制。我们发现PZH以剂量依赖的方式显著抑制HCT-8细胞的迁移和侵袭。此外,PZH处理抑制了TGF-β1信号通路关键介质的表达,如TGF-β1、Smad2/3和Smad4。此外,PZH处理抑制了TGF-β1通路的两个关键靶基因ZEB1和ZEB2的表达,导致间充质标志物N-钙黏蛋白的表达降低,上皮标志物E-钙黏蛋白的表达增加。此外,PZH处理上调了miR-200a、miR-200b和miR-200c的表达。总体而言,我们在本研究中的发现表明,PZH可以通过调节TGF-β1/ZEB/miR-200信号网络来抑制结肠癌细胞的转移,这可能是PZH发挥其抗癌功能的机制之一。